◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

INSIGHT MOLECULAR DIAGNOSTICS INC.

CIK: 1642380 SIC: 2835
$4.40M
Revenue
$-60.78M
Net Income
54.73%
Gross Margin
-1392.91%
Op. Margin
$-42.87M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 9 of 9 annual reports available (2016 - 2024)
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
+ Total Revenue $4.40M $1.88M $1.50M $958.00K $7.73M $1.22M - - - -
Revenue Growth % 134.0% 25.1% 56.9% -87.6% 535.4% nan% nan% nan% nan% nan%
Cost of Revenue $1.96M $1.05M $1.00M $880.00K $4.18M $1.85M - - - -
+ Gross Profit $2.41M $740.00K $413.00K $-18.00K $188.00K $-639.00K - - - -
Gross Margin % 54.7% 39.3% 27.5% -1.9% 2.4% -52.5% nan% nan% nan% nan%
Operating Expenses $63.73M $61.78M $25.55M $17.98M $74.40M $29.07M $22.24M $15.20M $18.85M $11.14M
Research & Development $12.34M $9.84M $9.29M $7.30M $13.63M $9.80M $6.79M $6.51M $7.17M $5.68M
+ Operating Income $-61.32M $-61.04M $-25.14M $-18.00M $-74.21M $-29.71M $-22.24M $-15.20M $-18.85M $-11.14M
Operating Margin % -1392.9% -3245.1% -1672.4% -1878.6% -960.4% -2443.3% nan% nan% nan% nan%
Interest Expense $163.00K $42.00K $7.00K $24.00K $114.00K $209.00K $171.00K $142.00K $130.00K -
Other Income/Expense $651.00K $462.00K $394.00K $-67.00K $-37.00K $27.00K $-3.00K $91.00K - -
Income Before Tax - - $-24.86M $-18.61M $-73.36M $-31.19M $-22.43M - - -
Income Tax Expense - - - - $-9.26M $-1.25M - - - -
+ Net Income $-60.78M $-60.66M $-27.78M $-72.90M $-64.10M $-29.93M $-22.43M $-15.75M $-19.38M $-11.17M
Net Margin % -1380.7% -3225.0% -1848.4% -7609.8% -829.5% -2461.5% nan% nan% nan% nan%
Basic EPS -3.20 -4.66 -3.75 -0.66 -0.72 nan nan nan nan nan
Diluted EPS -3.20 -4.66 -3.75 -13.25 nan nan nan nan nan nan
Basic Shares Outstanding 32.0M 13.1M 7.7M 111K 89K - - - - -
Diluted Shares Outstanding 32.0M 13.1M 7.7M 5.5M - - - - - -
Breakdown FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Cash & Cash Equivalents $8.64M $9.43M $19.99M $35.60M $7.14M $22.07M $8.03M $7.60M $10.17M
Accounts Receivable $1.61M $484.00K $2.01M $1.44M $203.00K - - - -
Inventory $410.00K - - - - - - - -
Other Current Assets $821.00K $643.00K $977.00K $1.20M $1.21M $505.00K $180.00K $168.00K $285.00K
Total Current Assets $11.76M $10.70M $25.54M $39.14M $9.23M $22.96M $8.64M $8.53M $12.70M
Property Plant & Equipment - - - - - - $614.00K $822.00K $688.00K
Goodwill - - - $18.68M $9.19M - - - -
Intangible Assets $14.61M $56.59M $61.63M $91.25M $15.01M - - $746.00K $988.00K
Other Non-current Assets $691.00K $463.00K $371.00K $264.00K $356.00K - - - -
Total Assets $35.08M $74.89M $100.09M $159.56M $55.42M $39.86M $9.52M $10.22M $14.45M
Accounts Payable $2.28M $953.00K $1.25M $2.45M $432.00K $469.00K $166.00K $175.00K $422.00K
Accrued Liabilities $1.94M $1.65M $1.77M $3.38M $3.47M - - - -
Total Current Liabilities $7.28M $7.19M $12.11M $14.12M $9.00M $4.44M $5.56M $4.45M $4.28M
Total Liabilities $47.35M $49.30M $60.50M $94.35M $21.94M $9.02M $6.09M $5.81M $4.58M
Common Stock $338.24M $310.30M $294.93M $252.95M $157.16M $124.58M $74.74M $59.97M $45.82M
Retained Earnings $-350.54M $-289.88M $-260.68M $-187.77M $-123.68M $-93.75M $-71.32M $-54.68M $-35.30M
Total Stockholders Equity $-12.27M $20.47M $34.29M $65.22M $33.48M $30.84M $3.42M $4.40M $9.86M
Total Liabilities & Equity $35.08M $74.89M $100.09M $159.56M $55.42M $39.86M $9.52M $10.22M $14.45M
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Net Income $-67.45M $-60.66M $-27.78M $-72.90M $-64.10M $-29.93M $-22.43M $-15.75M $-19.38M $-11.17M
Depreciation & Amortization $2.17M $1.48M $1.59M $1.53M - - - - - -
Stock-based Compensation $3.45M $1.75M $2.76M $10.04M $6.84M $5.07M $3.00M $1.48M $1.63M -
Deferred Income Tax - - - - $-9.26M $-1.25M - - - -
Change in Receivables $875.00K $1.13M $-109.00K $575.00K $1.23M $182.00K - - - -
Change in Inventory $571.00K $410.00K - - - - - - - -
Operating Cash Flow $-39.99M $-20.71M $-23.32M $-45.57M $-35.94M $-25.98M $-19.71M $-11.65M $-13.38M $-7.52M
Capital Expenditure $2.88M $516.00K $281.00K $4.34M $2.25M $1.23M $918.00K $31.00K $91.00K $106.00K
Acquisitions - - - - $607.00K $6.19M - - - -
Investing Cash Flow $-2.88M $-512.00K $-932.00K $-4.34M $-13.96M $-11.75M $-12.41M $-31.00K $843.00K $-181.00K
Debt Repayment - - - $1.32M $1.50M $375.00K $667.00K $800.00K $133.00K -
Stock Issued $97.63M $26.01M $13.85M $32.81M $65.26M $18.34M $48.85M $10.00M - -
Financing Cash Flow $96.16M $20.43M $12.19M $35.81M $78.36M $22.80M $47.87M $12.11M $9.97M $9.88M
Net Change in Cash $53.19M $-796.00K $-12.07M $-14.10M $28.46M $-14.93M $15.74M $434.00K $-2.57M $2.18M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $260.00K $115.00K $2.92M $395.00K
Cost of Revenue $121.00K $43.00K $1.11M $184.00K
Gross Profit $139.00K $50.00K $1.80M $145.00K
Operating Expenses $11.19M $13.56M $29.49M $27.56M
Research & Development $3.88M $2.82M $10.07M $7.58M
Operating Income $-11.05M $-13.52M $-27.69M $-27.41M
Interest Expense - - $69.00K $17.00K
Other Income/Expense $223.00K $53.00K $505.00K $316.00K
Income Tax Expense - - - -
Net Income $-10.85M $-13.49M $-27.27M $-27.15M
Basic EPS -0.34 -0.98 -0.91 -2.36
Diluted EPS -0.34 -0.98 -0.91 -2.36
Basic Shares Outstanding $32.03M $13.71M $29.94M $11.62M
Diluted Shares Outstanding $32.03M $13.71M $29.94M $11.62M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $18.69M $8.64M
Accounts Receivable $258.00K $1.61M
Inventory $471.00K $410.00K
Other Current Assets $1.24M $821.00K
Total Current Assets $21.39M $11.76M
Intangible Assets $14.60M $14.61M
Other Non-current Assets $672.00K $691.00K
Total Assets $43.94M $35.08M
Accounts Payable $1.06M $2.28M
Accrued Liabilities $2.23M $1.94M
Total Current Liabilities $7.66M $7.28M
Total Liabilities $53.13M $47.35M
Common Stock $368.52M $338.24M
Retained Earnings $-377.81M $-350.54M
Total Stockholders Equity $-9.20M $-12.27M
Total Liabilities & Equity $43.94M $35.08M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-10.85M $-13.49M $-27.27M $-27.15M
Depreciation & Amortization $584.00K $318.00K $1.63M $935.00K
Stock-based Compensation - - $1.50M $1.25M
Change in Receivables - - $-1.35M $-275.00K
Change in Inventory - - $61.00K $232.00K
Operating Cash Flow - - $-16.64M $-15.34M
Capital Expenditure - - $1.71M $302.00K
Investing Cash Flow - - $-1.71M $-302.00K
Stock Issued - - $29.14M $15.81M
Financing Cash Flow - - $28.32M $9.59M
Net Change in Cash - - $9.87M $-6.07M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading news...
TRENDING
Loading...